Summary:
Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death in Spain, affecting around 11% of individuals aged 40 to 80. COPD patients contribute significantly to primary care consultations and emergency room visits, placing considerable pressure on the healthcare system. Insufficient monitoring often leads to frequent episodes of instability and readmissions, causing significant socio-economic impact.
AstraZeneca, in collaboration with Tucuvi, has launched AZerca, an AI and conversational technology-based project to improve the control and quality of life for patients with COPD. AZerca allows healthcare professionals to remotely monitor COPD patients, reducing the need for in-person hospital visits. The program aims to optimize hospital resources, alleviate the burden of COPD on the healthcare system, and enhance patient outcomes.
Utilizing conversational AI called «LOLA,» the initiative involves regular phone calls to collect vital health information and detect potential deteriorations in patients’ conditions. Alerts are sent to healthcare professionals for early intervention. The program is currently implemented in two hospitals, with plans to expand to six in its first phase, involving more than 13 specialized healthcare professionals across various Spanish hospitals. The initiative is expected to last for 12 months.
Article written by Astrazeneca| Image by Pexels
30/11/2023
Source:
Astrazeneca
https://www.astrazeneca.es/medios/notas-prensa/2023/AstraZeneca_y_Tucuvi_presentan_AZerca_un_asistente_virtual_para_mejorar_el_seguimiento_de_la_EPOC.html#!